Related Experiment Video
Updated: Jun 18, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated
Pakkath Narayanan Arya1, Iyyappan Saranya1, Nagarajan Selvamurugan1
1Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India.
Abstract:
Osteogenic differentiation is a crucial process in the formation of the skeleton and the remodeling of bones. It relies on a complex system of signaling pathways and transcription factors, including Runt-related transcription factor 2 (RUNX2). Non-coding RNAs (ncRNAs) control the bone-specific transcription factor RUNX2 through post-transcriptional mechanisms to regulate osteogenic differentiation. The most research has focused on microRNAs (miRNAs) and long ncRNAs (lncRNAs) in studying how they regulate RUNX2 for osteogenesis in both normal and pathological situations. This article provides a concise overview of the recent advancements in understanding the critical roles of lncRNA/miRNA/axes in controlling the expression of RUNX2 during bone formation. The possible application of miRNAs and lncRNAs as therapeutic agents for the treatment of disorders involving the bones and bones itself is also covered.
Insights
Non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), regulate bone formation by controlling the RUNX2 transcription factor. These molecules offer potential therapeutic strategies for bone disorders.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Osteogenic differentiation is vital for skeletal development and bone repair.
- Runt-related transcription factor 2 (RUNX2) is a master regulator of osteogenesis.
- Non-coding RNAs (ncRNAs) modulate gene expression post-transcriptionally.
Purpose of the Study:
- To review recent advances in understanding lncRNA and miRNA regulation of RUNX2 in osteogenesis.
- To explore the therapeutic potential of ncRNAs in bone-related diseases.
Main Methods:
- Literature review of studies on ncRNAs, RUNX2, and osteogenic differentiation.
- Analysis of regulatory mechanisms involving lncRNA/miRNA axes.
- Examination of therapeutic applications.
Main Results:
- lncRNAs and miRNAs critically control RUNX2 expression during bone formation.
- Specific lncRNA-miRNA interactions fine-tune osteogenic pathways.
- Dysregulation of these axes is implicated in bone pathologies.
Conclusions:
- lncRNA/miRNA/RUNX2 axes are key regulators of osteogenesis.
- Targeting these ncRNAs presents a promising therapeutic avenue for bone disorders.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Master Transcription Regulators
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...

